Clinical Trials Logo

Filter by:
NCT ID: NCT00412789 Completed - Tumors Clinical Trials

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

Start date: August 2006
Phase: Phase 1
Study type: Interventional

The study will evaluate the safety and efficacy of Patupilone in adult patients with advanced solid tumors.

NCT ID: NCT00410735 Completed - Chronic Sinusitis Clinical Trials

Study of ONO-1078 in Patients With Chronic Sinusitis

Start date: December 2006
Phase: Phase 3
Study type: Interventional

To determine the efficacy and safety of ONO-1078 in patients with chronic sinusitis in a double-blind, randomized, placebo-controlled, parallel group, multi-center study

NCT ID: NCT00410358 Completed - Clinical trials for Advanced Solid Tumors

A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.

Start date: June 2006
Phase: Phase 1
Study type: Interventional

This study assesses the tolerability, safety, efficacy and pharmacokinetics of gimatecan in Japanese patients. Gimatecan is administered orally for five consecutive days, every 28 days, to adult patients with advanced solid tumors who have progressed despite standard therapy or for whom standard systemic therapy does not exist.

NCT ID: NCT00410124 Completed - Clinical trials for Metastatic Renal Cell Carcinoma

RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib

RECORD-1
Start date: November 2006
Phase: Phase 3
Study type: Interventional

To assess whether daily treatment with RAD001 could slow the growth and spread of metastatic carcinoma of the kidney. The safety of RAD001 was also to be studied in this trial.

NCT ID: NCT00409500 Completed - Healthy Clinical Trials

Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects

Start date: October 2006
Phase: Phase 1
Study type: Interventional

This study will evaluate safety, tolerability and pharmacokinetics of individual oral doses of AQW051 in Japanese healthy male subjects, and will also evaluate the effect of food on the pharmacokinetics of AQW051.

NCT ID: NCT00409357 Completed - Clinical trials for Benign Prostatic Hyperplasia

Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Start date: November 2004
Phase: Phase 2
Study type: Interventional

The primary objective is to assess the dose-response relationship of SL77.0499 10 (alfuzosin hydrochloride) 5 mg, 10 mg, 15 mg, and placebo once daily during a 12-week oral administration period for the efficacy in patients with lower urinary tract symptoms (LUTS) related to BPH. Secondary objectives are to assess the efficacy of each dose of alfuzosin as compared with placebo and to assess the safety of each dose of alfuzosin.

NCT ID: NCT00408382 Completed - Clinical trials for Coronary Artery Disease

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

Start date: n/a
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery disease

NCT ID: NCT00408239 Completed - Thromboembolism Clinical Trials

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement

PEARL-1
Start date: December 2006
Phase: Phase 2
Study type: Interventional

Evaluate the safety and tolerability of escalating oral doses of YM150 in patients undergoing elective primary total knee replacement surgery

NCT ID: NCT00408135 Completed - Infections Clinical Trials

Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections

Start date: August 2004
Phase: Phase 3
Study type: Interventional

The primary objective is to assess the safety of telithromycin (HMR 3647) (20% fine granules) 1g filling sachet in children with infections (Respiratory tract infections, Dermatological infections, Otorhinolaryngological infections, Dentistry/Oral surgery infections). Secondary objectives are to assess the clinical efficacy, bacteriological efficacy and acceptability of telithromycin (20% fine granules) 1g filling sachet in children with infections.

NCT ID: NCT00407745 Completed - Clinical trials for Spinal Cord Injuries

A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury

Start date: January 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate if pregabalin relieves nerve pain associated with spinal cord injury compared to placebo (pill that contains no active medicine). This study will also evaluate the safety of pregabalin in this patient population.